维普中文期刊产品整合服务
31篇 您的检索式:作者名="Brummendorf"
    题名 作者 年代 出处 被引量
1Asymmetric cell divisions sustain long-term hematopoiesis from single-sorted human fetal liver ceils显示文摘Brummendorf TH Dragowska W Zijlmans JM 1998J Exp Med1998,188,6:1
2Bosutinib显示文摘KELLER G SCHAFHAUSEN P BRUMMENDORF TH 2010Recent Results Cancer Res2010,184,:1
3Consequences of telomerase inhibition by BIBR1532 on proliferation and chemosensitivity of chondrosarcoma cell lines显示文摘D·Parsch U·Brassat T·H·Brummendorf 2008Cancer Investigation2008,26,6:1
4Novel aspects of therapywith the dual Src and Abl kinase inhibitor bosutinib in chronic myeloidleukemia显示文摘Keller-V Amsberg G Brummendorf TH 2012Expert Rev Anticancer Ther2012,12,9:1
5Telomere length in leukocyte subpopulations of patients with aplastic anemia 显示文摘Brummendorf T H Macie jewski J P Mak J 2001Blood2001,97,4:1
6Safety and efficacy of bosutinib (SKI-606) in chronic phase Philadelphia chromosome-positive chronic myeloid leukemia pa- tients with resistance or intolerance to imatinib 显示文摘CORTES JE KANTARJIAN HM BRUMMENDORF TH 2011Blood2011,118,17:1
7Bosutinib (SKI-606) exhibits clinical activity in patients with Philadelphia chromosome positive CML or ALL who failed imatinib显示文摘GAMBACORTI-PASSERINI C BRUMMENDORF T KANTA- R3IAN H et ol 2007J Clin Oncol2007,25,18:1
8Safety and efficacy of bosutinib (SKI - 606) in patients (pts) with chronic phase (CP) chronic myeloid leukemia (CML) following resistance or intolerance to imatinib (IM)显示文摘CORTES JE KANTARJIAN H BRUMMENDORF T et 01 2010J Clin Oncol2010,28,15:1
9Bosutinib is safe and active in patients (pts) with chronic phase (CP) chronic myeloid leukemia (CML) with resistance or intolerance to imatinib and other tyrosine kinase inhibitors显示文摘BRUMMENDORF TH CERVANTES F KIM D eta! 2008J Clin Oncol2008,26,15:1
10Telomeres and telomerase in chronic myeloid leukaemia: impact for pathogenesis, disease progression and targeted therapy 显示文摘Keller G Brassat U Braig M Heim D Wege H Brummendorf TH 2009Hematological oncology2009,27,:1
11Telomere length in leukocyte subpopulations of patients with aplastic anemia显示文摘Brummendorf TH Maciejewski JP Mak J 2001Blood2001,97,4:1
12Danusertib (formerly PHA-739358 )--a novel combined pan-Aurora kinases and third generation Bcr-Abl tyrosine kinase inhibitor显示文摘GONTAREWICZ A BRUMMENDORF TH 2010Recent Results Cancer Res2010,184,:1
13Statins Enhance Migratory Capacity by Upregulation of the Telomere Repeat-Binding Factor TRF2 in Endothelial Progenitor Cells显示文摘Ioakim Spyridopoulos Judith Haendeler Carmen Urbich Tim H. Brummendorf Hidemasa Oh Michael D. Schneider Andreas M. Zeiher Stefanie Dimmeler 2004Circulation2004,,:1
14Telomere length in leukocyte subpopulations of patients with aplastic anemia 显示文摘BRUMMENDORF T H MACIEJEWSKI J P MAK J 2001Blood2001,97,:1
15Prospective study of rabbit antithymocyte globulin and cyclosporine for aplastic anemia from the EBMT Severe Aplastic Anaemia Working Party显示文摘Judith C. Marsh Andrea Bacigalupo Hubert Schrezenmeier Andre Tichelli Antonio M. Risitano Jakob R. Passweg Sally B. Killick Alan J. Warren Theodora Foukaneli Mahmoud Aljurf H. A. Al-Zahrani Philip Schafhausen Alexander Roth Anke Franzke Tim H. Brummendorf 2012Blood2012,,23:1
16Consequences of telomerase inhibition by BIBR1532 on proliferation and chemosensitivity of chondrosarcoma cell lines显示文摘PARSCH D BRASSAT U BRUMMENDORF T H 2008Cancer Invest2008,26,6:1
17Telomere length in leukocyte sub-populations of patients with aplastic anemia显示文摘Brummendorf TH Maciejewski JP Young NS 2001Blood2001,97,4:1
18Replicative aging of human articular chondrocytes during ex vivo expansion 显示文摘Parsch D Brummendorf TH Richter W 2002Arthritis Rheum2002,46,11:1
19Telomere length in leukocyte subpopulations of patients with aplastic anemia显示文摘Brummendorf TH Macie Jewski JP Mak J 2001Blood2001,97,4:1
20Bosutinib (SKI-606) exhibits clinical activity in patients with Philadelphia chromosome positive CML or ALL who failed imatinib 显示文摘Gambacorti PC Brummendorf T Kantarjian H 2007ASCO Meeting Abstracts2007,25,:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费